Most Recent
Rebel Wilson’s evidence ‘complete revision of history’, court hears
Do not believe “any word” said by actor and director Rebel Wilson in her defence against a defamation case by actress Charlotte MacInnes, after her evidence was “obliterated” by her own witnesses, a silk has said at the close of trial.
Philips may face US-level damages in CPAP class action
Group members in a class action against Philips over alleged defective sleep apnea machines may seek to rely on US law, with potentially “major consequences” for how much damages they could receive, a court has heard. 
Alucobond class action members may be told to pursue 3A overseas
A class action that failed to prove 3A Composites and Halifax Vogel misled consumers about alleged flammable Alucobond cladding wants to notify group members they may be able to bring claims in Germany.
Sportsbet class action plaintiff can shield Maurice Blackburn chats
Sportsbet has won its argument about the scope of a waiver of privilege in a class action over unlawful betting services, but a judge has found that the lead plaintiff can still keep communications with Maurice Blackburn under wraps. 
Mastercard’s competition lawyers advised rewording deal, court told
Trial in a case alleging Mastercard misused its market power by striking deals with retailers to defend revenues against EFTPOS routing has heard external competition lawyers suggested removing the word 'routing' from its contract with Woolworths.
‘Makes no sense’: Activists tell High Court abattoir can’t own footage
An animal rights group has told the High Court it retains copyright in footage it took while trespassing on a Victorian abattoir and that it “makes no sense” for the slaughterhouse to have rights to the footage.
Former Boral execs mull lawsuit over cut to long-term incentives
Boral's former CEO Zlatko Tordorcevski and ex-CFO Tino La Spina have been granted discovery as they mull possible claims against their former employer for curbing their long-term incentive entitlements when they left in 2022.
Pharmacor can challenge patent term extension in AstraZeneca case
Pharmacor, which is facing infringement claims by AstraZeneca over its plans to launch a generic version of diabetes drug Forxiga, can tweak its cross-claim to challenge a patent term extension.
ASIC’s key claim against TelstraSuper fails, despite some success
The corporate watchdog’s first case under internal dispute resolution regulations has had mixed results, with a court finding compliance failures by Telstra Super but no under-resourcing.
Union loses challenge to Opal Packaging’s drug testing policy
A union has lost an appeal of a decision which found packaging company Opal Packaging was allowed to reintroduce drug and alcohol testing of staff under a new methodology while a union challenge was on foot.